The Lobular Breast Cancer Alliance (LBCA) is pleased to be partnering with the Society of Nuclear Medicine and Molecular Imaging (SNMMI) on a new SNMMI/Lobular Breast Cancer Alliance (LBCA) Invasive Lobular Carcinoma (ILC) Imaging Research Grant.
Applications are now being accepted for the $100,000 grant, a first-time collaboration between the two organizations, which aims to fund a research/project focused on advancing ILC imaging and/or cultivating new lobular breast cancer treatments to improve patient outcomes. This collaboration has also resulted in an inaugural change in the SNMMI grant application review process, as patient advocates will be voting members in this process.
“This new collaboration with SNMMI is so important. The ILC imaging grant will get us one step closer towards an understanding of how better to detect and monitor ILC tumors, which is so desperately needed,” commented LBCA Executive Director Laurie Hutcheson.
To be selected, research projects must focus on ILC and molecular imaging or therapy for lobular breast cancer. Priority projects may have molecular imaging as the primary focus of the proposed research, or alternatively, researchers may investigate methods that integrate other imaging and/or molecular science with radionuclide methods, including hybrid imaging techniques such as PET/CT, SPECT/CT and PET/MRI.
Those interested in learning more about the grant or submitting an application can visit SNMMI’s website.